A mathematical model of tumor-immune interactions

DOI10.1016/j.jtbi.2011.10.027zbMath1397.92358OpenAlexW2052208722WikidataQ51505011 ScholiaQ51505011MaRDI QIDQ1787000

Mark Robertson-Tessi, Alain Goriely, Ardith W. El-Kareh

Publication date: 26 September 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2011.10.027

zbMATH Keywords

tumor growth immunosuppression regulatory T cells TGF-\(\beta\)IL-10

Mathematics Subject Classification ID

Medical applications (general) (92C50) Cell biology (92C37)

Related Items (53)

Comparative study for optimal control nonlinear variable-order fractional tumor model ⋮ The impact of distributed time delay in a tumor-immune interaction system ⋮ Interlocked feedback loops balance the adaptive immune response ⋮ A cancer treatment based on synergy between anti-angiogenic and immune cell therapies ⋮ A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy ⋮ A mathematical model for pancreatic cancer growth and treatments ⋮ Dynamic aspects of tumour–immune system interaction under a periodic immunotherapy ⋮ Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies ⋮ The influence of time delay in a chaotic cancer model ⋮ Analysis of noise-induced phenomena in the nonlinear tumor-immune system ⋮ Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment ⋮ Mathematical modelling of cancer stem cell-targeted immunotherapy ⋮ Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions ⋮ Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors ⋮ An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol ⋮ A TUMOR-IMMUNE MODEL WITH MIXED IMMUNOTHERAPY AND CHEMOTHERAPY: QUALITATIVE ANALYSIS AND OPTIMAL CONTROl ⋮ A tumor-Immune interaction model with the effect of impulse therapy ⋮ Computational modeling to determine the effect of phenotypic heterogeneity in tumors on the collective tumor-immune interactions ⋮ Mathematical and numerical modelling of interference of immune cells in the tumour environment ⋮ Optimal control of inhibiting tumor, new approach to sufficient \(\varepsilon\)-optimality and numerical computation ⋮ Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer ⋮ Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study ⋮ IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancer ⋮ Control of tumor growth modeled by system of PDE, numerical analysis of optimality conditions ⋮ Implications of immune-mediated metastatic growth on metastatic dormancy, blow-up, early detection, and treatment ⋮ A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies ⋮ Global dynamics of a breast cancer competition model ⋮ A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS ⋮ Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma ⋮ A two-phenotype model of immune evasion by cancer cells ⋮ A comparison and catalog of intrinsic tumor growth models ⋮ MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS ⋮ Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy ⋮ A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications ⋮ Mathematical modeling of tumor-immune cell interactions ⋮ A mathematical model of cell-mediated immune response to tumor ⋮ Bifurcation analysis of a delayed mathematical model for tumor growth ⋮ Optimal control of variable-order fractional model for delay cancer treatments ⋮ Optimal treatment strategy for a tumor model under immune suppression ⋮ Identification of crucial parameters in a mathematical multiscale model of glioblastoma growth ⋮ Nonlinear dynamics in tumor-immune system interaction models with delays ⋮ Periodic and chaotic dynamics in a map-based model of tumor-immune interaction ⋮ A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy ⋮ A size and space structured model describing interactions of tumor cells with immune cells reveals cancer persistent equilibrium states in tumorigenesis ⋮ Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections ⋮ Complex dynamic behaviors of a tumor-immune system with two delays in tumor actions ⋮ Dynamics of breast cancer under different rates of chemoradiotherapy ⋮ Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives ⋮ An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data ⋮ Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy ⋮ A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies ⋮ Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response ⋮ Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative

Cites Work

This page was built for publication: A mathematical model of tumor-immune interactions